WaveMan · Form 4
Healy James insider trades
> Search tickers & screens ⌘K
LIVE

Healy James insider trades

Healy James has filed 54 Form 4s with the SEC that we hold, for Natera, Inc. (NTRA) (Director), KRTX (Director), YMAB (Director) and Bolt Biotherapeutics, Inc. (BOLT) (Director), among 10 companies in all. Across all of them we count 35 purchases worth $66.0M and 7 sales worth $46.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 644,000 shares of Natera, Inc. worth $37.8M, dated 2023-12-13. The first filing on our record is dated 2021-07-07 and the latest 2026-06-12.

Natera, Inc. (NTRA)

Director · 21 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-22P, purchase reported on Form 42,400$271.2K2021-07-26
2022-11-16S, sale reported on Form 42,400$90.5K2023-01-18
2023-12-13S, sale reported on Form 4644,000$37.8M2023-12-22

KRTX

Director · 9 filings · 9 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-02P, purchase reported on Form 4636$74.9K2021-07-07
2022-04-01P, purchase reported on Form 447$6.1K2022-04-14
2022-06-29P, purchase reported on Form 49,129$1.1M2022-07-01
2022-06-29P, purchase reported on Form 427,777$3.4M2022-07-01
2022-06-29P, purchase reported on Form 44,039$496.6K2022-07-01
2022-06-29P, purchase reported on Form 46,832$852.2K2022-07-01
2022-06-30P, purchase reported on Form 424,161$3.0M2022-07-01
2022-06-30P, purchase reported on Form 448,062$5.9M2022-07-01
2023-01-13S, sale reported on Form 46,027$1.2M2023-01-17

YMAB

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Bolt Biotherapeutics, Inc. (BOLT)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

CINC

Director, 10% owner · 4 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-11P, purchase reported on Form 4325,000$5.2M2022-01-13
2022-08-11P, purchase reported on Form 4500,000$15.0M2022-08-15
2022-08-11P, purchase reported on Form 46,000$180.0K2022-08-15
2022-11-28S, sale reported on Form 46,000$85.9K2023-02-27

Rapport Therapeutics, Inc. (RAPP)

Director · 4 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-06-10P, purchase reported on Form 4470,589$8.0M2024-06-10
2024-06-10P, purchase reported on Form 418,641$316.9K2024-06-10
2024-06-10P, purchase reported on Form 425,455$432.7K2024-06-10
2024-06-10P, purchase reported on Form 426,278$446.7K2024-06-10
2024-06-10P, purchase reported on Form 417,861$303.6K2024-06-10
2024-07-01P, purchase reported on Form 44,661$116.6K2024-07-03
2024-07-01P, purchase reported on Form 42,625$68.4K2024-07-03
2024-07-01P, purchase reported on Form 43,538$81.7K2024-07-03
2024-07-01P, purchase reported on Form 43,565$86.3K2024-07-03
2024-07-01P, purchase reported on Form 44,544$113.7K2024-07-03
2024-07-01P, purchase reported on Form 42,559$66.7K2024-07-03
2024-07-01P, purchase reported on Form 43,799$87.7K2024-07-03
2024-07-01P, purchase reported on Form 43,828$92.7K2024-07-03
2024-07-01P, purchase reported on Form 44,878$122.0K2024-07-03
2024-07-01P, purchase reported on Form 42,748$71.6K2024-07-03
2024-07-01P, purchase reported on Form 43,630$83.8K2024-07-03
2024-07-01P, purchase reported on Form 43,657$88.5K2024-07-03

BioAge Labs, Inc. (BIOA)

Director · 3 filings · 5 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-09-27P, purchase reported on Form 4588,888$10.6M2024-09-27
2024-09-27P, purchase reported on Form 426,497$476.9K2024-09-27
2024-09-27P, purchase reported on Form 418,353$330.4K2024-09-27
2024-09-27P, purchase reported on Form 421,814$392.7K2024-09-27
2024-09-27P, purchase reported on Form 411,113$200.0K2024-09-27

Coherus Oncology, Inc. (CHRS)

Director · 2 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-27S, sale reported on Form 4100,150$1.8M2021-09-29
2021-09-28S, sale reported on Form 448,329$829.8K2021-09-29
2021-09-29S, sale reported on Form 4286,076$4.6M2021-09-29

ArriVent BioPharma, Inc. (AVBP)

Director · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-01-30P, purchase reported on Form 4444,444$8.0M2024-01-31

Seaport Therapeutics, Inc. (SPTX)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1245624) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms